Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024312 (
lymphopenia
)
4,859
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The antiviral nucleoside analogue 2',3'-dideoxycytidine (ddC) is a DNA chain terminator and/or inhibitor of human immunodeficiency virus (HIV) reverse transcriptase. We evaluated the effects of ddC in 36 New Zealand white rabbits. Three/sex were assigned to a control group and 5 treatment groups (10-250 mg/kg/day) for 13 or 18 weeks. Blood samples were taken 1 week prior to treatment and weekly thereafter to termination with the exception of the 2 highest dose groups, where blood sample collection was terminated at week 13. Selected hematological analytes were measured weekly with the exception of prothrombin time (PT) and activated partial thromboplastin time (APTT). PT and APTT and selected biochemical analytes were measured prior to treatment, at 7 weeks, and after 13 weeks of treatment. All rabbits were necropsied. Giemsa and hematoxylin and eosin sections were prepared from methacrylate-embedded marrow. Hematological effects included decreases in red blood cell count, hemoglobin, hematocrit, and white blood cell count and increases in mean corpuscular volume and red cell distribution width. Platelets, platelet volume, PT, APTT, and mean corpuscular hemoglobin concentration values were variable or unchanged. Effects were dose-related, most were seen at 1 week, and they persisted to term. Bone marrow histopathologic changes included megalocytosis, erythroid hypoplasia, bizarre erythroid nuclear morphology, nuclear-cytoplasmic asynchrony, and increased mitotic figures.
Lymphopenia
caused by ddC plateaued at 2 weeks and persisted until termination. Heteropenia (neutropenia) was sporadic. Biochemical values for serum analytes were unchanged by treatment. The principal hematological effect of ddC upon the erythron was characterized as a nonregenerative
macrocytic anemia
with erythroid hypoplasia and megaloblastic erythropoiesis.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Hematological effects of 2',3'-dideoxycytidine in rabbits. 133 36
CBA/Ca male mice were given 3'-azido-3'-deoxythymidine (AZT) in drinking water (1 mg/ml) for up to 7 weeks. Water consumption and body weight decreased significantly. Neutropenia and
lymphopenia
were observed during and after exposure. Significant
macrocytic anemia
developed and disappeared as a function of red cell life span after stopping AZT intake. A microthrombocytosis was seen. Bone marrow cellularity and spleen colony-forming unit (CFU-s) content fell, but recovered completely and quickly after terminating AZT intake. Hemopoietic stem cell function measured by 2 different methods of rescuing fatally irradiated mice was normal 4 weeks after AZT exposure, suggesting that AZT treatment does not induce a long-lasting effect in genetic control of mitotic potential of stem cells. This is in marked contrast to exposure of CBA/Ca mice to benzene and ionizing radiation.
...
PMID:In vivo toxicity of 3'-azido-3'-deoxythymidine (AZT) on CBA/Ca mice. 223 Feb 84
The efficacy and outcome of bone marrow transplantation therapy following lethal irradiation were examined in syngeneic mice that had a hereditary
macrocytic anemia
(an/an) or were genotypically normal (+/+). Successful RBC and WBC replacement, based on blood cell parameters and donor genetic markers, were observed in all combinations of transplant therapy. Nevertheless, the an/an mice died prematurely several months after treatment, whether they received +/+ or an/an marrow cells. In contrast, the +/+ recipients of either +/+ or an/an marrow cells survived for at least 1 year after transplantation. Premature death of the an/an mice was associated with
lymphopenia
, anemia, kidney lesions, and severe pathogen-free pneumonitis. On the basis of our results, we hypothesize that the premature deaths of an/an mice are caused by a kind of chronic irradiation damage to which an/an mice are especially susceptible.
...
PMID:Deleterious effects of irradiation and bone marrow transplantation therapy in the genetically anemic an/an mouse. 264 75
The impact of diluted levels of polluted seawater from the Egyptian Mediterranean coast on reproductive, toxicological and hematological characteristics of Siganus rivulatus were determined. Mature fish were exposed to diluted levels of 7.5, 10 and 15 ml L(-1) polluted seawater. Hematological changes after 4, 15 and 30 days of exposure were measured. Erythrocytes decreased (p<0.05) as well as Packed Cell Volume (PCV) and Hemoglobin (Hb), indicating anemia developed to hypochromic
macrocytic anemia
at end of experiment. Leukocytes, increased (p<0.05), indicating susceptibility of fish to infection and stress. Granulocytic leukocytes, neutrophil and eosinophil increased. While
lymphocytes decreased
. Blood parameters of exposed fish revealed compensatory responses. The increase in developing hemocytoplast and myelocytes emphasize the compensatory and defensive reaction of fish to polluted water. Exposure to polluted water levels has a detrimental effect on gonads development, altered endocrine haemostasis, testosterone and progesterone levels decreased in females (p<0.05). While in male, progesterone level increased (p<0.01). Necrosis of spermatogenic cells and atresia of developing oocytes are pronounced at levels of 10 and 15 ml L(-1)polluted seawater. Also, has necrotic effect on fish organs. Vacuolation and necrosis occurs in liver and kidney. Melanomacrophage aggregates can be seen. Gills showed epithetial lifting and vascular widening. Results showed that, polluted water has serious consequences on Siganus rivulatus blood characteristics as well as organs cellular structure. It rendered fish anemiatic, altered reproductive hormones level, leading to necrosis of males spermatogenic cells and atresia of developing oocytes.
...
PMID:Effect of polluted water from the Egyptian Eastern Mediterranean coast on reproductive, toxicological and hematological characteristics of Siganus rivulatus. 2230 40